Andrea Goren's most recent trade in NAYA Biosciences was a trade of 81,000 Stock option (right to buy) done . Disclosure was reported to the exchange on May 18, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
NAYA Biosciences | Andrea Goren | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 81,000 | 81,000 | - | - | Stock option (right to buy) | |
NAYA Biosciences | Andrea Goren | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2022 | 15,197 | 15,197 | - | - | Stock Option | |
NAYA Biosciences | Andrea Goren | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2022 | 5,361 | 17,861 | - | 0 | Common Stock | |
NAYA Biosciences | Andrea Goren | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 3.26 per share. | 05 Oct 2021 | 30,674 | 76,383 | - | 3.3 | 99,997 | Common Stock |